Tau protein's role in early brain development
A non-canonical role for tau in early human brain development
Researchers are exploring how the tau protein behaves in developing human brain cells to help people affected by autism, epilepsy, or early-life brain injury.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Iowa NIH-funded |
| Lab location | 1 site (Iowa City, United States) |
| Project ID | NIH-11296881 on NIH RePORTER |
What this research studies
If I or a family member has autism, epilepsy, or had a neonatal brain injury, this work looks at how the tau protein works in human brain tissue during development. The team will use fully human-based laboratory models to see how changes in tau can disrupt brain cell connections and networks. They will compare human tau findings to what has been learned in animals and consider whether drugs that lower tau in adults might be safe or useful for younger brains. The goal is to understand normal tau function so future treatments can be repurposed safely for developmental conditions.
Who could benefit from this research
Good fit: People with autism, epilepsy, or a history of early-life hypoxic-ischemic brain injury who can provide samples or join related observational efforts would be most relevant.
Not a fit: Patients seeking an immediate clinical treatment are unlikely to benefit directly because this is lab-based research focused on understanding biology.
Why it matters
Potential benefit: Could enable safer repurposing of tau-lowering treatments to reduce network problems in autism, epilepsy, or after early-life brain injury.
How similar studies have performed: Tau-lowering drugs have been safe and effective at reducing tau levels in adults, but applying this approach to developmental disorders is novel and not yet proven.
Where this research is happening
Iowa City, United States
- University of Iowa — Iowa City, United States (Active)
Researchers
- Principal investigator: Hefti, Marco Matthias — University of Iowa
- Study coordinator: Hefti, Marco Matthias
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.